Class Action Lawsuit Filed Against Chemours Over Overstated Demand and Lowered 2026 Guidance
Oct 12, 2026
Chemours faces a class action lawsuit over alleged overstated Opteon demand and lowered 2026 guidance, following a 19% stock decline due to oversupplied inventory channels.
Show all 25 updates